Mivebresib (Standard)
Mivebresib (Standard) is the analytical standard of Mivebresib. This product is intended for research and analytical applications. Mivebresib (ABBV-075) is a potent and orally active bromodomain and extraterminal domain (BET) bromodomain inhibitor. Mivebresib binds to BRD4 with a Ki of 1.5 nM[1].
Product Specifications
CAS Number
1445993-26-9
Product Name Alternative
ABBV-075 (Standard)
UNSPSC
12352005
Target
Apoptosis; Epigenetic Reader Domain; Reference Standards
Related Pathways
Apoptosis; Epigenetics; Others
Field of Research
Cancer
Smiles
CCS(=O)(NC1=CC=C(OC2=CC=C(F)C=C2F)C(C3=CN(C)C(C4=C3C=CN4)=O)=C1)=O
Molecular Formula
C22H19F2N3O4S
Molecular Weight
459.47
References & Citations
[1]EJ Faivre et al. Abstract 4694: ABBV-075, a novel BET family inhibitor, disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC432079 20 µg
EIF4ENIF1 (NM_001164501) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC042922-100 1x 100 µL
Uroplakin 1A (Urothelial Differentiation Marker) (UPK1A/2922), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-C376250-1G 1 g
4-(3-Chloro-4-fluorophenylamino)-7-fluoro-6-nitroquinazoline
Sign In for Pricing
View Details